BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

SpectruMedix (SMDX) Expands Into Human Bacterial And Viral Pathogen Detection Markets


10/19/2005 5:12:50 PM

STATE COLLEGE, Pa., April 14 /PRNewswire/ -- SpectruMedix LLC announces the launch of a new application package to the Reveal(TM) Genetic Analysis System; human bacterial and viral pathogen detection and identification. The Reveal(TM) HBVP System will include complete chemistry and instrumentation methodology for accurate, low cost, high throughput detection and identification of bacterial and viral pathogens.

The Reveal(TM) HBVP System will include primers, dNTPs, buffer, stabilizers all contained in a single vial; Reveal(TM) DNA Polymerase and methods for use in capillary electrophoresis instrumentation complete the application package.

The first set of assays include the following: Chlamydia trachomatis, Bordetella pertussis, Bordetella parapertussis, Staphlocococcus mecA, E. coli Shiga like toxin II, Herpes simplex virus, Cytomegalovirus (CMV), Varicella- zoster virus(VZV).

This new technology expands the functionality of the Reveal(TM) Genetic Analysis System, which is known for DNA variant discovery and identification, fragment analysis and sequencing. The HBVP System takes advantage of the ability to use intercalating dyes to detect unlabelled double-stranded DNA. The new technology will allow greater penetration into the molecular pathology and bacterial identification markets.

About SpectruMedix LLC

SpectruMedix LLC is an innovative manufacturer of high throughput capillary electrophoresis instrumentation for genetic analysis. The company's proprietary technology for on-column detection of DNA and temperature gradient capillary electrophoresis allows SpectruMedix to address an unmet need for high throughput screening for mutations present in DNA samples as well as a number of other genetic analysis applications. Systems are available in 24, 96, 192, and 384 capillary configurations.

More information on the Reveal(TM) System can be obtained from http://www.spectrumedix.com/ .

SpectruMedix LLC

CONTACT: Kevin Gutshall, Director of Sales and Business Development ofSpectruMedix LLC, +1-814-867-8600, ext. 266



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES